Search results
Moderna to seek parity for RSV shot (NASDAQ:MRNA)
Seeking Alpha· 6 days agoModerna (MRNA) stock gains as the company highlights its upcoming RSV shot, expecting the U.S. regulators to endorse it on par with rival products. Read more here.
Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoModerna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript May 2, 2024 Moderna, Inc. beats...
Moderna, Inc. (NASDAQ:MRNA) Expected to Earn Q3 2025 Earnings of $1.30 Per Share
ETF DAILY NEWS· 3 days agoModerna, Inc. (NASDAQ:MRNA – Free Report) – Equities research analysts at William Blair lifted their Q3 2025 EPS estimates for Moderna in a report released ...
Moderna First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 5 days agoModerna (NASDAQ:MRNA) First Quarter 2024 Results Key Financial Results Revenue: US$167.0m (down 91%...
Moderna (MRNA) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 6 days agoModerna (MRNA) delivered earnings and revenue surprises of 14.48% and 33.88%, respectively, for the...
Will withdrawal of AstraZeneca vaccine affect your next COVID booster jab?
Yahoo News UK· 8 hours agoAppointments were offered from April and UK Health Security Agency advice on bookings set out the...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via AOL· 6 days agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected...
Moderna ends gene editing alliance with Metagenomi
BioPharma Dive via Yahoo Finance· 6 days agoMetagenomi said the companies’ decision to part ways followed a “strategic prioritization” undertaken by Moderna, which has made several investments in...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 6 days agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
Tech Bytes: Moderna partners with OpenAI to expedite drug development processes
Proactive Investors· 2 days agoModerna, the biotechnology firm best known for its COVID-19 vaccines, has partnered with artificial...